News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry Yael L. Maxwell November 05, 2024
News Conference News TCT 2024 Bleeding After MCS in DanGer Shock: When, Where, and What to Do? Caitlin E. Cox October 31, 2024
Presentation TCT 2024 TCT 681: Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Non-Significant Obstructive Coronary Artery Disease Presenter: Shoichi Kuramitsu October 30, 2024
Presentation TCT 2024 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial Presenter: Hongbo Yang October 30, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
Presentation TCT 2024 Modulation of Antiplatelet Therapy After PCI Presenter: Michelle O'Donoghue October 28, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
Presentation TCT 2024 TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia Presenter: Haoyu Wu October 27, 2024
Presentation TCT 2024 TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis Presenter: Ahmed Younes October 27, 2024
Presentation TCT 2024 TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials Presenter: Mobeen Haider October 27, 2024
Presentation TCT 2024 TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT Presenter: Victor Alfonso Jimenez Diaz October 27, 2024
Presentation TCT 2024 TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials Presenter: BERNARDO KREMER October 27, 2024
Presentation TCT 2024 TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting Presenter: Woo Jin Jang October 27, 2024
Presentation TCT 2024 TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry Presenter: Niels van der Sangen October 27, 2024
Presentation TCT 2024 TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention Presenter: Yao Jiang October 27, 2024
Presentation TCT 2024 TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft Presenter: IFTIKHAR CH October 27, 2024
Presentation TCT 2024 Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry Presenter: Francesco Pelliccia October 27, 2024
Presentation TCT 2024 TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial Presenter: Mauro Gitto October 27, 2024